ストックスクリーナーアプリを入手
25.16
2.25%
-0.58
Pacira Biosciences Inc (PCRX) 最新ニュース
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 14, 2025 in Pacira BioSciences, Inc. LawsuitPCRX - ACCESS Newswire
PCRX Investors Have Opportunity to Lead Pacira BioSciences, Inc. Securities Fraud Lawsuit - PR Newswire
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel ... - The Bakersfield Californian
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PCRX - GlobeNewswire Inc.
Investors who lost money on Pacira BioSciences, Inc.(PCRX) should contact Levi & Korsinsky about pending Class ActionPCRX - Morningstar
Class Action Filed Against Pacira BioSciences, Inc. (PCRX)March 14, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
Investors in Pacira BioSciences, Inc. Should Contact Levi & Korsinsky Before March 14, 2025 to Discuss Your RightsPCRX - ACCESS Newswire
PCRX Investors Have Opportunity to Lead Pacira BioSciences, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Pacira to Report 2024 Financial Results on Thursday February 27, 2025 - GlobeNewswire
Investors in Pacira BioSciences, Inc. Should Contact The Gross Law Firm Before March 14, 2025 to Discuss Your RightsPCRX - PR Newswire
PACIRA BIOSCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS - GlobeNewswire
PCRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Lowey Dannenberg Notifies Pacira Biosciences, Inc. - GlobeNewswire
PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. - GlobeNewswire Inc.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Pacira Biosciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesPCRX - PR Newswire
Investors who lost money on Pacira BioSciences, Inc. (PCRX) - GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel ... - The Bakersfield Californian
Lost Money on Pacira BioSciences, Inc.(PCRX)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - GuruFocus.com
Yousif Capital Management LLC Has $340,000 Stock Position in Pacira BioSciences, Inc. (NASDAQ:PCRX) - Defense World
Zacks Research Issues Positive Outlook for PCRX Earnings - MarketBeat
Zacks Research Issues Pessimistic Forecast for PCRX Earnings - MarketBeat
PCRX Shareholders Have Opportunity to Lead Pacira BioSciences, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - Markets Insider
Pacira BioSciences, Inc. (NASDAQ:PCRX) Receives $22.78 Consensus Price Target from Analysts - MarketBeat
PCRX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Brokerages Set Pacira BioSciences, Inc. (NASDAQ:PCRX) Price Target at $22.78 - Defense World
Shares Of Pacira BioSciences Inc (NASDAQ: PCRX): Are They Overvalued Compared To Others? - Stocks Register
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira - StreetInsider.com
What is Zacks Research’s Estimate for PCRX FY2024 Earnings? - Defense World
PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira - PR Newswire
Empowered Funds LLC Buys 11,149 Shares of Pacira BioSciences, Inc. (NASDAQ:PCRX) - MarketBeat
PCRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
Pacira BioSciences, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before March 14, 2025 to Discuss Your RightsPCRX - Morningstar
Q4 EPS Estimate for Pacira BioSciences Boosted by Analyst - Defense World
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira - Marketscreener.com
The Gross Law Firm Reminds Pacira BioSciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 14, 2025PCRX - Morningstar
Lawsuit Alert: Investors in shares of Pacira BioSciences, Inc. - openPR
PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA - GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel - The Bakersfield Californian
A Guide To The Risks Of Investing In Pacira BioSciences Inc (PCRX) - Knox Daily
Pacira BioSciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before March 14, 2025 to Discuss Your RightsPCRX - PR Newswire
Shareholders that lost money on Pacira BioSciences, - GlobeNewswire
Pacira BioSciences, Inc. (NASDAQ:PCRX) Shares Sold by Janney Montgomery Scott LLC - MarketBeat
ROSEN, LEADING INVESTOR COUNSEL, Encourages Pacira - GlobeNewswire
Pacira BioSciences Inc (PCRX) Shares Decline Despite Market Challenges - The News Heater
Shareholders that lost money on Pacira BioSciences, Inc.(PCRX) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - PR Newswire
PCRX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Pacira BioSciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - Markets Insider
PCRXPacira BioSciences, Inc. Latest Stock News & Market Updates - StockTitan
Is Pacira BioSciences Inc (PCRX) a good investment opportunity? - US Post News
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
3.23%
3.94%
大文字化:
|
ボリューム (24 時間):